A study to assess effectiveness and safety of second-line treatment with paclitaxel and ramucirumab after a first-line treatment
Latest Information Update: 25 Jul 2021
At a glance
- Drugs Irinotecan (Primary) ; Paclitaxel (Primary) ; Ramucirumab (Primary) ; Taxanes
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms LINE
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology
- 24 Jul 2020 New trial record
- 04 Jul 2020 Results presented at the 22nd World Congress on Gastrointestinal Cancer